Virodex: Superior replacements to Triton X-100

Download all the available literature here:

Virodex™

indicates required field

First name:

Please provide your first name

Last name:

Please provide your last name

Email address:

E-mail is not valid

By checking this box, you consent to receive marketing emails from Croda. You can find out more about how your data is stored and amend your marketing preferences at any time by visiting here

We need your consent

Supporting Literature

Enter your contact details to receive supporting materials.

Virodex™ TXR-1 TDS

Virodex™ TXR-2 TDS

Virodex™ TXR-1 and TXR-2: Safe and effective viral inactivation and cell lysis

Virodex™ TXR-1

Virodex™ TXR-1 is a readily biodegradable, nonionic surfactant for viral inactivation and cell lysis, meeting the needs of biopharmaceutical applications as an effective and safe replacement for the...

Virodex™ TXR-2

Virodex™ TXR-2 is a 40% biobased, nonionic surfactant for viral inactivation and cell lysis, meeting the needs of biopharmaceutical applications as an effective and safe replacement for the...

Key benefits of our Virodex™ range include:

Sustainable, REACH-compliant, and cGMP EXCiPACT manufactured

Compendial grade, with known parenteral applications*

No risk of nitrosamine formation

Equivalent performance to Triton™ X-100, with better performance than other replacements on the market

Offered in a range of pack sizes, including single-use

And more...

Hear directly from our experts...

Watch our expert Dr. Kritika Bajaj discuss our product range in more detail and learn how Virodex™ could be the solution to your replacement requirement.

Learn more

From Triton X-100 to Virodex: exploring our innovative solution to the Triton X-100 ban

For those who have previously relied on Triton™ X-100 as a surfactant or detergent in their manufacturing processes there is now an urgent need to find a suitable replacement. Explore Croda's innovative solution to your formulation challenges - Virodex!

Concerns about Triton™ X-100 have been an ongoing discussion across multiple regulatory authorities around the world

Triton™ X-100, a non-ionic surfactant with a hydrophilic polyethylene oxide chain and a hydrophobic aromatic group1, has found widespread use in the biopharmaceutical industry with applications including virus inactivation1, cell lysis and membrane permeation2. Even though it is used heavily throughout the industry, the degradation products from Triton™ X-100 exhibit long-lasting estrogenic properties in fish, birds, and mammals, causing disruptions to their endocrine systems, raising concerns in the bioprocessing industry.